Health Trials

Stage IV NSCLC

2

Review clinical trials related to Stage IV NSCLC. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Evaluating a Fasting-mimicking Diet in Combination With Immunotherapy in Patients With Non-small Cell Lung Cancer

The purpose of this study is to learn the effects of fasting on cancer cells while you get maintenance treatment.

Participants needed: 66
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: VA Office of Research and DevelopmentUpdated: Nov 10, 2025Locations: 4
Eligibility criteria

18 years at the time of informed consent [+6]

Self-reported weight loss of > 10% in the 6 weeks prior to study entry [+7]

Read more
Status: Not yet recruiting

Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib

The purpose of this study is to observe the safety and efficacy of Aspirin combined with Trametinib and Dalafenib in the treatment of advanced BRAF V600E mutated non-small cell lung cancer (NSCLC)

Participants needed: 36
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityUpdated: Oct 12, 2023
Eligibility criteria

Inoperable stage IIIB-IV patients with non-small cell lung cancer; [+5]

The patient is currently receiving other anticoagulant therapy; [+4]

Read more